MILLENNIUM MANAGEMENT LLC - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$1,799,000
-74.6%
449,747
-68.8%
0.00%
-81.8%
Q3 2019$7,073,000
-24.1%
1,443,591
-9.9%
0.01%
-21.4%
Q1 2019$9,313,000
+2.7%
1,602,920
+137.8%
0.01%0.0%
Q4 2018$9,071,000
-25.7%
673,940
+7.1%
0.01%
-6.7%
Q3 2018$12,210,000
-43.8%
629,044
-26.0%
0.02%
-48.3%
Q2 2018$21,734,000
+8.8%
850,305
-14.3%
0.03%
+7.4%
Q1 2018$19,983,000
+579.5%
991,716
+576.7%
0.03%
+575.0%
Q4 2017$2,941,000
-90.4%
146,554
-90.1%
0.00%
-91.5%
Q3 2017$30,635,000
+110.2%
1,479,214
+50.2%
0.05%
+80.8%
Q2 2017$14,573,000
+25.3%
984,678
+35.1%
0.03%
+23.8%
Q1 2017$11,627,000
+14.5%
728,981
-9.6%
0.02%0.0%
Q4 2016$10,157,000
+1109.2%
806,103
+2587.0%
0.02%
+2000.0%
Q3 2016$840,000
-84.0%
30,000
-84.3%
0.00%
-92.3%
Q1 2016$5,244,000
-84.9%
191,401
-81.2%
0.01%
-82.2%
Q4 2015$34,784,000
+565.8%
1,016,467
+459.0%
0.07%
+630.0%
Q3 2015$5,224,000
+157.7%
181,839
+301.4%
0.01%
+150.0%
Q2 2015$2,027,000
-30.8%
45,305
-46.5%
0.00%
-20.0%
Q1 2015$2,928,000
+14.7%
84,682
-9.2%
0.01%0.0%
Q4 2014$2,552,00093,2340.01%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q2 2018
NameSharesValueWeighting ↓
Empirical Capital Management, LLC 479,018$9,298,0008.38%
Rhenman & Partners Asset Management AB 1,174,411$22,795,0002.28%
Capital Investment Advisory Services, LLC 153,842$2,986,0001.40%
Cortina Asset Management, LLC 1,238,420$24,038,0001.12%
Investors Research Corp 92,027$1,786,0001.02%
Matarin Capital Management, LLC 697,387$13,536,282,0000.87%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 853,687$16,570,0000.59%
RICE HALL JAMES & ASSOCIATES, LLC 809,257$15,708,0000.56%
BROADVIEW ADVISORS LLC 156,700$3,042,0000.52%
FRONTIER CAPITAL MANAGEMENT CO LLC 3,535,217$68,619,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders